Payer perceptions of value frameworks

A paper by Westrich et al. (2023) examines payer perceptions of five different value frameworks. Value frameworks of interest included:

American Society of Clinical Oncology (ASCO) Value Framework, Drug Pricing Lab’s Drug Abacus (formerly Memorial Sloan Kettering Cancer Center’s Drug Abacus), Institute for Clinical and Economic Review (ICER) value assessment framework and evidence reportsThe Innovation and Value Initiative (IVI)’s Open-Source Value Project models, National Comprehensive Cancer Network (NCCN)’s Evidence Blocks

The authors conducted a double-blind, web-based survey to assess payers’ perceptions of these value frameworks. Overall, 51 health care payer respondents found that the the most important factors when selecting a value framework was that (i) appropriate metrics and outcomes were included, (ii) comparative clinical effectiveness information was provided and (iii) the results were methodologically rigorous and unbiased.

Among the 5 value frameworks, ICER, NCCN and ASCO were the value frameworks considered most useful for formulary decisions, while ICER was far and away the most useful for drug price negotiations.

https://www.jmcp.org/doi/epdf/10.18553/jmcp.2023.29.5.582?role=tab